Actions of CP-060S on veratridine-induced Ca2+ overload in cardiomyocytes and mechanical activities in vascular strips

European Journal of Pharmacology

Volumn 312, Issue 2, 1996, Pages 195-202

  Tamura, Kazuhiko ^a   Suzuki, Yoshiyuki ^a   Koga, Takaki ^a   Akima, Michitaka ^a   Kato, Tatsuya ^a   Nabata, Hiroyuki ^a  

^a CHUGAI PHARMACEUTICAL CO LTD   (Japan)

Author keywords

Ca2+ channel; Ca2+ overload; Cardiomyocyte; CP 060S; Smooth muscle, vascular; Veratridine

Indexed keywords

CALCIUM; CALCIUM CHANNEL BLOCKING AGENT; DILTIAZEM; VERATRIDINE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CALCIUM CELL LEVEL; CONTROLLED STUDY; ENANTIOMER; HEART MUSCLE CELL; HEART PROTECTION; IN VITRO STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; THORACIC AORTA; VASODILATATION;

EID: 0030603215     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/0014-2999(96)00460-8     Document Type: Article

References (38)

1. Asano, T. and H. Hidaka, 1984. Vasodilatory action of HA1004 [N-(2-guanidinoethyl)-5-isoquinolinesulfonamide], a novel calcium antagonist with no effect on cardiac function, J. Pharmacol. Exp. Ther. 231, 141.
2. Arunlakshana, O. and H.O. Schild, 1959, Some quantitative uses of drug antagonists, Br. J. Pharmacol. 14, 48.
3. Bhatnagar, A., S.K. Srivastava and G. Szabo, 1990, Oxidative stress alters specific membrane currents in isolated cardiac myocytes, Circ. Res. 67, 535.
4. 2+-distribution in the isolated working rabbit heart after ischaemia. A time-related study, Am. J. Pathol. 126, 92.
5. Bourdillon, P.D.V. and P.A. Poole-Wilson, 1981, Effects of ischaemia and reperfusion on calcium exchange and mechanical function in isolated rabbit myocardium, Cardiovasc. Res. 15, 121.
6. Burnashev, N.A., A.I. Undrovinas, I.A. Fleidervish, J.C. Makielski and L.V. Rosenshtraukh, 1991, Modulation of cardiac sodium channel gating by lysophosphatidylcholine, J. Mol. Cell. Cardiol. 23 (Suppl. 1), 23.
7. Bush, L.R., J.L. Romson, J.L. Ash and B.R. Lucchesi, 1982, Effects of diltiazem on extent of ultimate myocardial injury resulting from temporary coronary artery occlusion in dogs, J. Cardiovasc. Pharmacol. 4, 285.
8. Corr, P.B., K.A. Yamada, M.H. Creer, A.D. Sharma and B.E. Sobel, 1987, Lysophosphoglycerides and ventricular fibrillation early after onset of ischemia, J. Mol. Cell. Cardiol. 19 (Suppl. 5), 45.
9. Garner, J.A., D.J. Hearse and M. Bernier, 1990, R56865, a potent new antiarrhythmic agent, effective during ischemia and reperfusion in the rat heart, J. Cardiovasc. Pharmacol. 16, 468.
10. Gibson, R.S., W.E. Boden, P. Theroux, H.D. Strauss, C.M. Pratt, M. Gheorghiade, R.J. Caphone, M.H. Crawford, R.C. Schlant, R.E. Kleiger, P.M. Young, K. Schechtman, M.B. Ferryman, R. Roberts and The Diltiazem Reinfarction Study Group, 1986, Diltiazem and reinfarction in patients with non-Q-wave myocardial infarction. Results of a double-blind, randomized, multicenter trial, New Engl. J. Med. 315, 423.
11. 2+ indicators with greatly improved fluorescence properties, J. Biol. Chem. 260, 3440.
12. 2+ exchange, Circ. Res. 71, 547.
13. Ignarro, L.J. and P.J. Kadowitz, 1985, The Pharmacological and physiological role of cyclic GMP in vascular smooth muscle relaxation, Annu. Rev. Pharmacol. 25, 171.
14. 2+-overload inhibitor, on myocardial injury in ischemic, reperfused porcine hearts, J. Cardiovasc. Pharmacol. 25, 163.
15. Leibowitz, M.D., J.B. Sutro and B. Hille, 1986, Voltage dependent gating of veratridine-modified Na channels, J. Gen. Physiol. 87, 25.
16. Li, Q., R.A. Altschukd and B.T. Stokes, 1987, Quantitation of intracellular free calcium in single adult cardiomyocytes by fura-2 fluorescence microscopy: calibration of fura-2 ratios, Biochem. Biophys, Res. Commum. 147, 120.
17. Malloy, C.R., D.C. Buster, M.M. Castro, C.F. Geraldes, F.M. Jeffrey and A.D. Sherry, 1990, Influence of global ischaemia on intracellular sodium in the perfused rat heart, Magn. Reson. Med. 15, 33.
18. Nelson, M.T., J.B. Patlak, J.F. Worley and N.B. Starden, 1990, Calcium channels, potassium channels, and voltage dependence of arterial smooth muscle tone, Am. J. Physiol. 259, C3.
19. Powell, T. and V.W. Twist, 1976, A rapid technique for the isolation and purification of adult cardiac muscle cells having respiratory control and a tolerance to calcium, Biochem. Biophys, Res. Commun. 72, 327.
20. Powell, T., D.A. Terrar and V.W. Twist, 1980, Electrical properties of individual cells isolated from adult rat ventricular myocardium, J. Physiol. (London), 302, 131.
21. 2+ influx, Nature, 364, 809.
22. Reimer, K.A. and R.B. Jennings, 1984, Verapamil in two reperfusion models of myocardial infarction. Temporary protection of severely ischemic myocardium without limitation of ultimate infarction size, Lab. Invest. 51, 655.
23. Schaffer, S.W., B. Saffer, A. Scappa and J.R. Williamson, 1973, Mode of action of the calcium ionophores X-537A and A23187 on cardiac contractility, Biochem. Pharmacol. 23, 1609.
24. Seamon, K.B., W. Padgett and J.W. Daly, 1981, Forskolin: unique diterpene activator of adenylate cyclase in membranes and in intact cells, Proc. Natl. Acad. Sci. USA, 78, 3363.
25. Sirnes, P.A., K. Overskeid, T.R. Pedersen, J. Bathen, A. Drivenes, G.S. Froland, J.K. Kjekshus, K. Landmark, R. Rokseth, K.E. Sirnes, A. Sundoy, B.R. Torjussen, K.M. Westlund and B.A. Wik, 1984, Evolution of infarct size during the early use of nifedipine in patients with acute myocardial infarction: The Norwegian Nifedipine Multicenter Trial, Circulation, 70, 638.
26. Sobel, B.E., P.B. Corr, A.K. Robison, R.A. Goldstein, F.X. Witkowski and M.S. Klein, 1978, Accumulation of lysophosphoglycerides with arrhythmogenic properties in ischemic myocardium, J. Clin. Invest. 62, 546.
27. Somlyo, A.V., M. Bond, A.P. Somlyo and A. Scarpa, 1985, Inositoltriphosphate-induced calcium release and contraction in vascular smooth muscle, Proc. Natl. Acad. Sci. USA, 82, 5231.
28. Steenbergen, C., E. Murphy, J.A. Watss and R.E. London, 1990, Correlation between cytosolic free calcium, contracture, ATP, and irreversible ischemic injury in perfused rat heart, Circ. Res. 66, 135.
29. + channels in guinea pig ventricular myocytes, Am. J. Physiol. 264, H454.
30. 2+-overload in reperfused ischemic myocardium, Annu. Rev. Physiol. 52, 543.
31. 2+ overload and impairs function in anoxic rat heart, J. Mol. Cell. Cardiol. 22, 57.
32. The Danish Study Group on Verapamil in Myocardial Infarction, 1990, Effect of verapamil on mortality and major events after acute myocardial infarction (The Danish verapamil infarction trial II - DAVIT II), Am. J. Cardiol. 66, 779.
33. The Multicenter Diltiazem Postinfarction Trial Research group, 1988, The effect of diltiazem on mortality and reinfarction after myocardial infarction, New Engl. J. Med. 319, 385.
34. Undrovinas, A.I., I.A. Fleidervish and J.C. Makielski, 1992, Inward sodium current at resting potentials in single cardiac myocytes induced by the ischemic metabolite lysophosphatidylcholine, Circ. Res. 71, 1231.
35. 23Na NMR study, J. Mol. Cell. Cardiol. 23, 297.
36. Ver Donck, L. and M. Borgers, 1991, Myocardial protection by R56865: a new principle based on prevention of ion channel pathology, Am. J. Physiol. 261, H1828.
37. Verscheure, Y., G. Pouget, F. De Courtois, B. Le Grand and G.W. John, 1995, Attenuation by R56865, a novel cytoprotective drug, of regional myocardial ischemia-and reperfusion-induced electrocardiographic disturbances in anesthetized rabbits, J. Cardiovasc. Pharmacol. 25, 126.
38. Wilcox, R.G., J.R. Hampton, D.C. Banks, J.S. Birkhead, I.A.B. Brooksby, C.J. Burns-Cox, M.J. Hayes, M.D. Joy, A.D. Malcolm, H.G. Mather and J.M. Rowley, 1986, Trial of early nifedipine in acute myocardial infarction; the Trent study, Br. Med. J. 293, 1204.